AbbVie Shares Drop 6% Amid Concerns About Humira (NYSE:ABBV) Sales Slump by Technical Terrence Team 04/26/2024 0 vzfotos AbbVie Stock (New York Stock Exchange: ABBV) fell 6% in afternoon trading Friday in the wake of the drugmaker's ...
Alpine Modifies Acazicolcept Deal with AbbVie, Ends Phase 2 Study Early (NASDAQ:ALPN) by Technical Terrence Team 12/21/2023 0 mikhail_petrov-96 Alpine immune sciences (NASDAQ:ALPN) said it amended its 2020 option and license agreement with AbbVie (ABBV) for acazicolcept and ...
The agreement between AbbVie and Cerevel came after an unusual options negotiation by Technical Terrence Team 12/08/2023 0 georgeemployee There was an unusual spike in options trading related to Cerevel Therapeutics (NASDAQ:CERE) days before AbbVie (New York Stock ...
Pfizer, AbbVie, GSK, Eli Lilly among drugmakers to raise prices (NYSE:PFE) by Technical Terrence Team 01/15/2023 0 Sorry Pharmaceutical companies started 2023 strong, raising prices for about 450 drugs this month, with more price hikes expected, according ...
List of BlackRock Spot Bitcoin ETFs That Sent Crypto Prices Higher on Tuesday Added in August as ‘Standard Practice’ 10/25/2023